Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$86.06 - $137.93 $4.34 Million - $6.96 Million
50,470 New
50,470 $4.71 Million
Q1 2023

May 12, 2023

SELL
$104.0 - $122.92 $10.1 Million - $11.9 Million
-96,649 Reduced 57.29%
72,056 $8.37 Million
Q4 2022

Feb 10, 2023

BUY
$84.98 - $122.67 $12.2 Million - $17.6 Million
143,519 Added 569.84%
168,705 $19.1 Million
Q3 2022

Nov 14, 2022

SELL
$76.35 - $94.18 $1.54 Million - $1.9 Million
-20,128 Reduced 44.42%
25,186 $2.03 Million
Q2 2022

Aug 12, 2022

BUY
$67.99 - $132.89 $3.08 Million - $6.02 Million
45,314 New
45,314 $3.38 Million
Q1 2022

May 16, 2022

SELL
$94.08 - $130.2 $148,081 - $204,934
-1,574 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$129.87 - $162.82 $204,415 - $256,278
1,574 New
1,574 $845,000
Q3 2020

Nov 13, 2020

SELL
$95.51 - $112.95 $4.01 Million - $4.74 Million
-41,954 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$62.68 - $105.34 $2.63 Million - $4.42 Million
41,954 New
41,954 $17 Million
Q4 2019

Feb 14, 2020

SELL
$36.62 - $57.29 $189,581 - $296,590
-5,177 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$35.53 - $43.8 $183,938 - $226,752
5,177 New
5,177 $772,000
Q2 2019

Aug 14, 2019

SELL
$27.84 - $38.92 $75,279 - $105,239
-2,704 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$28.07 - $38.18 $75,901 - $103,238
2,704 New
2,704 $322,000
Q4 2018

Feb 15, 2019

SELL
$26.99 - $37.37 $60,538 - $83,820
-2,243 Closed
0 $0
Q3 2018

Nov 15, 2018

BUY
$23.35 - $36.72 $52,374 - $82,362
2,243 New
2,243 $320,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.9B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.